Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease.

[1]  R. Trevisan,et al.  Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. , 1997, Journal of the American Society of Nephrology : JASN.

[2]  B. Krolewski,et al.  Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. , 1994, The Journal of clinical investigation.

[3]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[4]  M. Steffes,et al.  Renal interstitial expansion in insulin-dependent diabetes mellitus. , 1993, Kidney international.

[5]  K. Earle,et al.  Intracellular pH and Na+/H+ antiport activity of cultured skin fibroblasts from diabetics. , 1992, Kidney international.

[6]  K. Earle,et al.  Na+/H+ Antiport Activity and Cell Growth in Cultured Skin Fibroblasts of IDDM Patients With Nephropathy , 1992, Diabetes.

[7]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[8]  K. Earle,et al.  Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. , 1992, The New England journal of medicine.

[9]  M. Kashgarian,et al.  The pathobiology of the mesangium. , 1992, Kidney international.

[10]  N. Nahman,et al.  Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. , 1992, Kidney international.

[11]  H. Rodemann,et al.  Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  H. Parving,et al.  Glomerular Structure and Function in Diabetic Nephropathy: Early to Advanced Stages , 1990, Diabetes.

[13]  I. Nishio,et al.  Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats. Difference of response to growth factor, intracellular free calcium concentration and DNA synthesizing cell cycle. , 1990, Atherosclerosis.

[14]  J. Chambers,et al.  Intraventricular Septal Hypertrophy in Type 1 Diabetic Patients with Microalbuminuria or Early Proteinuria , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[15]  R. Prewitt,et al.  Captopril Reduces Aortic and Microvascular Growth in Hypertensive and Normotensive Rats , 1990, Hypertension.

[16]  L L Vindeløv,et al.  A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. , 1990, Cytometry.

[17]  A. Fogo,et al.  Evidence for the central role of glomerular growth promoters in the development of sclerosis. , 1989, Seminars in nephrology.

[18]  B. Chavers,et al.  Mesangial Expansion as a Central Mechanism for Loss of Kidney Function in Diabetic Patients , 1989, Diabetes.

[19]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[20]  K. Dittmann,et al.  Selective enrichment and biochemical characterization of seven human skin fibroblasts cell types in vitro. , 1989, Experimental cell research.

[21]  G. Jerums,et al.  Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics. , 1988, Journal of Hypertension.

[22]  R. Schimke,et al.  Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Dittmann,et al.  Human skin fibroblasts in vitro differentiate along a terminal cell lineage. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Knowler,et al.  Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.

[25]  M. Lorenzi,et al.  High Glucose Prolongs Cell-Cycle Traversal of Cultured Human Endothelial Cells , 1987, Diabetes.

[26]  H. Keen,et al.  Raised arterial pressure in parents of proteinuric insulin dependent diabetics. , 1987, British medical journal.

[27]  T. Norwood,et al.  Proliferative potential of human fibroblasts: An inverse dependence on cell size , 1987, Journal of cellular physiology.

[28]  S. Kreiner,et al.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.

[29]  B. Brenner,et al.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Krolewski,et al.  The changing natural history of nephropathy in type I diabetes. , 1985, The American journal of medicine.

[31]  S. Schwartz,et al.  Polyploid nuclei in human artery wall smooth muscle cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Schwartz,et al.  Alterations in Vascular Smooth Muscle Mass in the Spontaneously Hypertensive Rat: Role of Cellular Hypertrophy, Hyperploidy, and Hyperplasia , 1982, Circulation research.

[33]  B. Mcfarland,et al.  Lifespans of diabetic and non-diabetic fibroblasts in vitro. Results of replicate determinations. , 1980, Experimental cell research.

[34]  E. Bierman,et al.  Effects of Glucose and Sorbitol on Proliferation of Cultured Human Skin Fibroblasts and Arterial Smooth-muscle Cells , 1978, Diabetes.

[35]  A. Rosenbloom,et al.  Insulin-dependent Childhood Diabetes: Normal Viability of Cultured Fibroblasts , 1978, Diabetes.

[36]  R. Gleason,et al.  Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. , 1978, Science.

[37]  D. Rowe,et al.  Abnormalities in Proliferation and Protein Synthesis in Skin Fibroblast Cultures from Patients with Diabetes Mellitus , 1977, Diabetes.

[38]  R. Fleischmajer,et al.  Werner's syndrome. , 1973, The American journal of medicine.

[39]  C. Epstein,et al.  Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. , 1970, Laboratory investigation; a journal of technical methods and pathology.

[40]  S. Goldstein,et al.  DIABETES MELLITUS AND AGING: DIMINISHED PLATING EFFICIENCY OF CULTURED HUMAN FIBROBLASTS , 1969 .

[41]  N Veall,et al.  Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. , 1969, Clinical science.

[42]  S. Goldstein.  Lifespan of cultured cells in progeria. , 1969, Lancet.

[43]  M. Simonsen.  CARE OF THE DYING. , 1965, Lancet.

[44]  H. Keen,et al.  AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS. , 1963, Lancet.

[45]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.